{"symbol":"ABBV","fiscalQuarter":"Q2-2023","reportDate":"2023-07-27","reportTime":"BMO","status":"reported","company":{"name":"AbbVie Inc.","sector":"Health Care","industry":"Biotechnology"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/ABBV/earnings/Q2-2023","postBrief":{"headline":"AbbVie Beats on EPS, Stock Up 4.9%","keyNumbers":[{"metric":"EPS","actual":"$2.91","expected":"N/A","surprise":"+4.49%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record, and the analysis is based solely on numerical results."},"guidanceChanges":{"summary":"No guidance data is available for this quarter.","changes":[]},"whatItMeans":"AbbVie reported a stronger-than-expected EPS, which led to a positive stock reaction, increasing by 4.9%. However, there was no revenue data provided, and no guidance updates were shared. Investors may view the EPS beat as a sign of underlying strength in the company's operations.","metaDescription":"AbbVie Inc. (ABBV) Q2 2023 earnings: EPS beat by 4.49%. Stock up 4.9%. Full breakdown."}}